We are building this new website to better deliver information. Find out more. We are building this new website to better deliver information. Find out more.
Let us know what you think.

Meningococcal disease

Information about meningococcal disease, vaccines and recommendations for vaccination from the Australian Immunisation Handbook

Vaccination for certain groups of people is funded under the National Immunisation Program and by states and territories.

Page history

Last updated: 
23 April 2019
Last reviewed: 
23 April 2019
15 February 2019

Changes to dose schedule for Bexsero, and Variations from product information.

View details
6 June 2018

Changes to recommendations.

View details

Definitions

4vMenPV
quadrivalent meningococcal polysaccharide vaccine
PRP
polyribosylribitol phosphate
DTPa
diphtheria-tetanus-acellular pertussis vaccine
IPV
inactivated poliomyelitis vaccine
13vPCV
13-valent pneumococcal conjugate vaccine
MMR
measles-mumps-rubella
MMRV
measles-mumps-rubella-varicella
23vPPV
23-valent pneumococcal polysaccharide vaccine
dTpa
diphtheria-tetanus-acellular pertussis vaccine, reduced antigen content formulation
GBS
Guillain-Barré syndrome
7vPCV
7-valent pneumococcal conjugate vaccine
ATAGI
Australian Technical Advisory Group on Immunisation
ID
intradermal
PT
pertussis toxoid
SC
subcutaneous
AIDS
acquired immunodeficiency syndrome
JE
Japanese encephalitis
WA
Western Australia
CDNA
Communicable Diseases Network Australia